928 related articles for article (PubMed ID: 8704180)
21. Epstein-Barr virus as an agent of haematological disease.
Tosato G; Taga K; Angiolillo AL; Sgadari C
Baillieres Clin Haematol; 1995 Mar; 8(1):165-99. PubMed ID: 7663046
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population.
Itakura O; Yamada S; Narita M; Kikuta H
Oncogene; 1996 Oct; 13(7):1549-53. PubMed ID: 8875994
[TBL] [Abstract][Full Text] [Related]
23. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases.
Quintanilla-Martínez L; Lome-Maldonado C; Ott G; Gschwendtner A; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Blood; 1997 Jan; 89(2):644-51. PubMed ID: 9002968
[TBL] [Abstract][Full Text] [Related]
24. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
Correa RM; Fellner MD; Durand K; Redini L; Alonio V; Yampolsky C; Colobraro A; Sevlever G; Teyssié A; Benetucci J; Picconi MA
J Med Virol; 2007 Apr; 79(4):401-7. PubMed ID: 17311329
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
28. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
29. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
[TBL] [Abstract][Full Text] [Related]
30. Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP-1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children.
Tacyildiz N; Cavdar AO; Ertem U; Oksal A; Kutluay L; Uluoglu O; Lin JC
Leukemia; 1998 Nov; 12(11):1796-805. PubMed ID: 9823956
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus.
Shibata D; Weiss LM; Hernandez AM; Nathwani BN; Bernstein L; Levine AM
Blood; 1993 Apr; 81(8):2102-9. PubMed ID: 8386027
[TBL] [Abstract][Full Text] [Related]
32. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.
Suzumiya J; Ohshima K; Takeshita M; Kanda M; Kawasaki C; Kimura N; Tamura K; Kikuchi M
Leuk Lymphoma; 1999 Nov; 35(5-6):567-78. PubMed ID: 10609794
[TBL] [Abstract][Full Text] [Related]
33. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
35. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations.
Knecht H; Raphaël M; McQuain C; Rothenberger S; Pihan G; Camilleri-Broët S; Bachmann E; Kershaw GR; Ryan S; Kittler EL; Quesenberry PJ; Schlaifer D; Woda BA; Brousset P
Blood; 1996 Feb; 87(3):876-81. PubMed ID: 8562956
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
Kingma DW; Shad A; Tsokos M; Fest T; Otsuki T; Frekko K; Werner E; Werner A; Magrath I; Raffeld M; Jaffe ES
Am J Surg Pathol; 1996 Dec; 20(12):1511-9. PubMed ID: 8944045
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
38. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
[TBL] [Abstract][Full Text] [Related]
39. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
Itakura O; Kikuta H
Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
[TBL] [Abstract][Full Text] [Related]
40. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]